
The consensus that drug manufacturers are at fault for high prescription prices comes even though only half the respondents said they were taking medication themselves.

The consensus that drug manufacturers are at fault for high prescription prices comes even though only half the respondents said they were taking medication themselves.

Although the introduction of new specialty drugs and increased investments into personal health data security, moderating forces will keep healthcare spending growth in check in 2016, according to a report from PwC's Health Research Institute.

Arkansas, Delaware, and Pennsylvania have all received tentative approval from HHS Secretary Sylvia Mathews Burwell to set up their own state-based insurance exchanges and move their residents off the federally facilitated marketplace.

Even though there hasn't been much public discussion from the Obama administration in regards to contingency plans should the Supreme Court rule in favor of the plaintiffs in King v. Burwell, there is likely much talk going on behind the scenes, explained Susan Dentzer, senior health policy adviser at the Robert Wood Johnson Foundation.

Leading up to the Supreme Court's decision in the case of King v. Burwell, Avik Roy, senior fellow at the Manhattan Institute, discusses in what ways Congress should potentially act if the plaintiffs receive a favorable ruling, who is to blame more if subsidies are removed from the federal marketplace, and how much time there will be for a patch to prevent millions of Americans losing financial assistance and subsequently their health insurance.

A new policy emerged from the annual meeting of the American Medical Association that calls for increased access to and coverage of integrated medical and behavioral healthcare services for patients.

An analysis of the Medicaid expansion plans of 6 states that have been granted Section 1115 waivers identified both the promise and limits that have emerged through these alternative expansion approaches.

The American Journal of Accountable Care recently interviewed Dr Jain about his decision to join CareMore, CareMore's innovative care model, and his perspectives on US healthcare.

This manuscript describes a structural alternative that builds upon the vision of the ACO, positions it centrally in the healthcare experience, and overcomes current limitations in delivering care.














This week CMS released their third round of annual data, the value-based topics of the American Society of Clinical Oncology gained new ground, and The American Journal of Managed Care will travel to their 75th session of the American Diabetes Association in Boston.

The report found a 6.5% increase in the compound annual growth rate during the 5-year period leading up to 2014.

A healthcare blog from experts at The Commonwealth Fund evaluates how the Affordable Care Act is transforming care delivery across institutions.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
